ATAI Life Sciences NV
NASDAQ:ATAI

Watchlist Manager
ATAI Life Sciences NV Logo
ATAI Life Sciences NV
NASDAQ:ATAI
Watchlist
Price: 1.19 USD Market Closed
Market Cap: 199.7m USD
Have any thoughts about
ATAI Life Sciences NV?
Write Note

ATAI Life Sciences NV
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ATAI Life Sciences NV
Net Change in Cash Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
ATAI Life Sciences NV
NASDAQ:ATAI
Net Change in Cash
-$145.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bayer AG
XETRA:BAYN
Net Change in Cash
-€2.2B
CAGR 3-Years
-43%
CAGR 5-Years
-38%
CAGR 10-Years
N/A
Merck KGaA
XETRA:MRK
Net Change in Cash
€796m
CAGR 3-Years
N/A
CAGR 5-Years
-29%
CAGR 10-Years
7%
MPH Health Care AG
XETRA:93M1
Net Change in Cash
€2.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dermapharm Holding SE
XETRA:DMP
Net Change in Cash
€885k
CAGR 3-Years
-67%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
PharmaSGP Holding SE
XETRA:PSG
Net Change in Cash
€8.1m
CAGR 3-Years
N/A
CAGR 5-Years
16%
CAGR 10-Years
N/A
No Stocks Found

ATAI Life Sciences NV
Glance View

Market Cap
199.7m USD
Industry
Pharmaceuticals

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company engages in the treatment of mental health disorders. The company is headquartered in Berlin, Berlin and currently employs 81 full-time employees. The company went IPO on 2021-06-18. The firm is aiming to transform the treatment of mental health disorders.

ATAI Intrinsic Value
0.02 USD
Overvaluation 98%
Intrinsic Value
Price

See Also

What is ATAI Life Sciences NV's Net Change in Cash?
Net Change in Cash
-145.6m USD

Based on the financial report for Dec 31, 2023, ATAI Life Sciences NV's Net Change in Cash amounts to -145.6m USD.

What is ATAI Life Sciences NV's Net Change in Cash growth rate?
Net Change in Cash CAGR 1Y
15%

Over the last year, the Net Change in Cash growth was 15%.

Back to Top